Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-08-03

Clinical Trial Update: Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung

View source ↗

Summary

A completed clinical trial from Tel-Aviv Sourasky Medical Center examining soluble factors and particulate matter in induced sputum and exhaled breath condensat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Asthma, Chronic Obstructive Pulmonary Disease | Status: COMPLETED